Form D · Biotechnology
RedLeaf Biologics, Inc.
Lexington, KY · CIK 0001677182
Offering snapshot reported Nov 7, 2019 · SEC filing
- Reported sold
- $750K Offering amount: $750K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $350K Reported outside-investor minimum
- First sale
- Sep 6, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2019 | Initial | $750,000 | No comparison | 2 | SEC filing |
| Dec 19, 2016 | Amendment | $5 | -$4,995vs Dec 5, 2016 | 1 | SEC filing |
| Dec 5, 2016 | Initial | $5,000 | No comparison | 1 | SEC filing |
| Jun 16, 2016 | Initial | $250,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-352841
Source: Form D, filed Nov 7, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Baker | Director |
| Seth De Bolt | Director, Executive |
| Murray Phimester | Executive |
| Christopher Somerville | Director |
| Chris Somerville | Director |
| Jordan Wood | Executive |
| Robert Jordan Wood | Executive |
| Heather Youngs | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
145 Graham Ave. Astecc Building Suite A159
Lexington, KY, 40506
Lexington, KY, 40506